학술논문

SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances
Document Type
Article
Source
In: Journal of Experimental and Clinical Cancer Research. (Journal of Experimental and Clinical Cancer Research, December 2022, 41(1))
Subject
Language
English
ISSN
17569966